RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. The Column Group
T

The Column Group portfolio

The Column Group has 8 portfolio companies on record at Recent Funding, with 4 investments in the last 12 months.

Type: Venture capital.
Portfolio on Recent Funding: 8.
Deals, last 12 months: 4.
Rounds led: 10 of 17.
Capital in their rounds: $1.28B.
Latest deal: TriGemX Bio · Oct 1, 2026.
About this page

It is a venture capital firm based in San Francisco, US, founded in 2007. It led 10 of the 17 rounds it joined. Its most recent investment on record is TriGemX Bio's $94M funding round in October 2026, which it led, alongside Viking Global Investors and TCG Crossover. By category, its portfolio leans toward Health and bio (8) and Consumer and social (2). It has co-invested with Samsara Biocapital, Nextech Invest and Lux Capital, most often Samsara Biocapital (6 rounds).

About The Column Group

Firm type: Venture capital.
Headquarters: San Francisco, US.
Founded: 2007.
Stages: Seed, Series A, Series B.
Sectors: Biotech, Deep Tech, Healthtech, Longevity.
Leads rounds: No.
Portfolio companies: 51.
Exits: 9.
Rounds led: 8.

Fund returns

FundVintageSizeNet IRRTVPIDPIAs of
The Column Group Fund Opportunity Fund III2022—0.2%1.01x0.34xNov 30, 2025
The Column Group Fund V2022—-19.1%0.77x0.00xNov 30, 2025
Column Group IV2019—-1.8%0.95x0.07xJun 30, 2025
Column Group III2016—7.7%1.25x0.78xJun 30, 2025
Column Group II2014—7.8%2.40x1.88xJun 30, 2025
The Column Group, L.P.2005—23.4%2.10x0.79xDec 31, 2016

What The Column Group invests in

The Column Group recent investments

CompanyRoundDateAlongside
TTriGemX Bioround · $94M · leadViking Global Investors, TCG Crossover (lead)
NNura BioSeries B+ · $73.8M · leadnone named
AAtavistik BioSeries B+ · $40MLux Capital, Regeneron Ventures, RA Capital Management (lead) +1
AAtavistik BioSeries B+ · $120M · leadLux Capital, Regeneron Ventures, Nextech Invest (lead)
NNilo TherapeuticsSeries A · $101M · leadDCVC Bio (lead), Bill & Melinda Gates Foundation, Lux Capital (lead) +1
AA2 BiotherapeuticsSeries B+ · $80MSamsara Biocapital
NNura BioSeries A · $68M · leadEuclidean Capital, Samsara Biocapital, Sanofi Ventures
AAccent TherapeuticsSeries B+ · $75MEcoR1 Capital, Mirae Asset Venture Investment, Droia Ventures +6

How The Column Group invests

StageDealsCapital in rounds
Series B+ 9 53%$731.3M
Series A 7 41%$455M
round 1 6%$94M
YearDealsCapital in rounds
2018 1 6%$40M
2019 1 6%$57M
2020 4 24%$263.5M
2021 2 12%$168M
2023 1 6%$100M
2024 2 12%$143M
2025 3 18%$301M
2026 3 18%$207.8M

The Column Group portfolio companies

CompanyRound with The Column GroupTotal raisedLatest raise
TTriGemX Bio
Health and bio
round · $94M · lead$94MOct 1, 2026
round
NNura Bio
Health and bio
Series B+ · $73.8M · lead$141.8MJun 22, 2026
Series B+
AAtavistik Bio
Health and bio
Series B+ · $40M$220MMar 5, 2026
Series B+
NNilo Therapeutics
Health and bio
Series A · $101M · lead$101MOct 8, 2025
Series A
AA2 Biotherapeutics
Health and bio
Series B+ · $80M$270.5MJan 10, 2025
Series B+
AAccent Therapeutics
Health and bio
Series B+ · $75M$178MJan 23, 2024
Series B+
SSynthekine
Health and bio
Series B+ · $100M · lead$290MJan 6, 2023
Series B+
HHexagon Bio
Health and bio
Series A · $47M · lead$109MOct 23, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Net returns as reported by the public-pension and foundation LPs invested in each fund.

Firm profile and fund returns: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 17 rounds on Recent Funding that name The Column Group. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists The Column Group, which is a subset of its real portfolio. API: /api/v1/investors/the-column-group (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy